Co-Diagnostics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Co-Diagnostics, Inc. (CODX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 1.05% for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-24.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2022-03-24
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-03-31 was 1.56%.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 1.05%, a 32.69% decline from fiscal 2019.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2019 was 1.56%, a 47.12% decline from fiscal 2018.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2018 was 2.95%, a 92.81% increase from fiscal 2017.
- Co-Diagnostics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2017 was 1.53%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2020-12-31 | 1.05% 10-K · filed 2022-03-24 | |||
| 2020-09-30 | 1.05% 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | 1.05% 10-Q/A · filed 2020-11-03 | |||
| 2020-03-31 | 1.56% 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | 1.56% 10-K · filed 2021-03-25 | |||
| 2019-09-30 | 1.56% 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | 1.56% 10-Q/A · filed 2020-11-03 | |||
| 2018-12-31 | 2.95% 10-K · filed 2020-03-30 | |||
| 2018-09-30 | 3.07% 10-Q · filed 2018-11-14 | |||
| 2017-12-31 | 1.53% 10-K · filed 2019-04-01 | |||
| 2017-09-30 | 1.53% 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |